New Vernon Capital Holdings Ii LLC Biogen Inc. Transaction History

New Vernon Capital Holdings Ii LLC

  • $186 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019
SELL
$216.71 - $338.96 $158,848 - $248,457
-733 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$278.5 - $352.75 $42,053 - $53,265
151 Added 25.95%
733 $221,000
Q3 2018

Nov 13, 2018
BUY
$293.51 - $383.83 $170,822 - $223,389
582 New
582 $206,000

Others Institutions Holding BIIB

# of Institutions
993
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track New Vernon Capital Holdings Ii LLC Portfolio

Follow New Vernon Capital Holdings Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email